Oppenheimer for Equity Research.

I completely sold on equity research, it's more for me. I recently completed and Internship at EY in the SaT department, which is fairly similar to investment banking and I'm not interested in doing it as a full-time job. I've been looking around and not a lot of people spoke about Oppenheimer as an investment bank.

What do you guys think about Oppenheimer? Are they good? What's the hiring process like, is it technical? What type of candidates do they look for? Is it like GS where you need to come from HBS and have a 4.0? 

Thanks in advance. 

WSO Elite Modeling Package

  • 6 courses to mastery: Excel, Financial Statement, LBO, M&A, Valuation and DCF
  • Elite instructors from top BB investment banks and private equity megafunds
  • Includes Company DB + Video Library Access (1 year)

Comments (5)

Sep 14, 2021 - 9:02pm

As opposed to banking, the quality and prestige of ER is less dependent on the firm and more dependent on the analyst in question.

For instance, an ER analyst at Cowen, which is a LMM IB, could be 100% considered better (and clear more money) than Goldman's top ER analyst.

If you think about it, there is no deal flow in ER, which means no prestige associated with larger deals. At the end of the day, everyone is covering the same stocks and selling their research to the same buyside. And if you work for a smaller firm and don't want to be analyst #39 covering Apple, we'll then great, you can pick up coverage on a smaller cap company that only has 4 analysts covering it and add incrementally more value.

So yes, Oppenheimer is on the map.

Most Helpful
  • Associate 1 in ER
Sep 15, 2021 - 1:53pm

I recently went through their process. First step was a video interview with analyst and the more senior associate. Mix of technical and behavioral. The next step was a modeling and writing test, which was somewhat challenging. After that, you speak to a variety of other members in the broader department to get a feel for cultural fit.

The team I interviewed with seemed to have a good vision for expanding their coverage. The analyst was relatively new as the much more senior analyst had left recently. However, he seemed familiar and comfortable in the space.

The people I spoke with made it seem like research was the company's primary focus and flagship product. It definitely seems like research would punch above it's weight compared to its IB deal flow and "rankings". Oppenheimer is definitely recognized within the research community, but someone else can definitely speak to the quality and reputation better than I can.

Hope this helps!

Sep 21, 2021 - 11:01pm

A consequatur eum reprehenderit consequatur magnam. Et voluptatum quas rerum suscipit excepturi nisi. In cupiditate expedita quia minima rerum illo.

Voluptas unde rem vel. Dolorem repellat voluptas ea quis eius dicta. Voluptas sint aut unde eos.

Start Discussion

Total Avg Compensation

September 2021 Investment Banking

  • Director/MD (10) $853
  • Vice President (39) $363
  • Associates (220) $232
  • 2nd Year Analyst (134) $154
  • 3rd+ Year Analyst (30) $147
  • Intern/Summer Associate (103) $143
  • 1st Year Analyst (486) $135
  • Intern/Summer Analyst (377) $82